Elisabeth Emilsen

Oslo, 0310, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases.

A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases.

Journal: Translational oncology
Published: December 06, 2018

MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma.

MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma.

Journal: Human pathology
Published: January 24, 2016

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma.

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma.

Journal: BMC cancer
Published: November 25, 2014

Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma.

Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma.

Journal: Cancer medicine
Published: August 28, 2014

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis.

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis.

Journal: Cancer biology & therapy
Published: November 30, 2012

Synthetic retinoid CD437 induces apoptosis and acts synergistically with TRAIL receptor-2 agonist in malignant melanoma.

Synthetic retinoid CD437 induces apoptosis and acts synergistically with TRAIL receptor-2 agonist in malignant melanoma.

Journal: Biochemical and biophysical research communications
Published: March 05, 2012

MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival.

MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival.

Journal: Gynecologic oncology
Published: February 27, 2012

High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy.

High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy.

Journal: PloS one
Published: January 16, 2012

Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.

Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.

Journal: BMC cancer
Published: October 24, 2011
Showing 1-9 of 9

Last Updated: 09/26/2026